|
1
|
Compare D, Rocco A and Nardone G: Risk
factors in gastric cancer. Eur Rev Med Pharmacol Sci. 14:302–308.
2010.PubMed/NCBI
|
|
2
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Cancer Epidemiology. Springer; pp.
467–477. 2009, View Article : Google Scholar
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J
and Sung JJ: Dysregulation of cellular signaling in gastric cancer.
Cancer Lett. 295:144–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou
S, Ding J and Wu K: Bird's-eye view on gastric cancer research of
the past 25 years. J Gastroenterol Hepatol. 20:360–365. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuzuhara T, Suganuma M, Kurusu M and
Fujiki H: Helicobacter pylori-secreting protein Tipα is a potent
inducer of chemokine gene expressions in stomach cancer cells. J
Cancer Res Clin Oncol. 133:287–296. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suzuki H, Yamamoto E, Nojima M, Kai M,
Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, et al:
Methylation-associated silencing of microRNA-34b/c in gastric
cancer and its involvement in an epigenetic field defect.
Carcinogenesis. 31:2066–2073. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiao F, Zhang K, Gong P, Wang L, Hu J, Lu
S and Fan H: Decreased miR-30b-5p expression by DNMT1 methylation
regulation involved in gastric cancer metastasis. Mol Biol Rep.
41:5693–5700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei Q, Zhou W, Wang W, Gao B, Wang L, Cao
J and Liu ZP: Tumor-suppressive functions of leucine zipper
transcription factor-like 1. Cancer Res. 70:2942–2950. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yanagihara I, Yamagata M, Sakai N,
Shukunami C, Kurahashi H, Yamazaki M, Michigami T, Hiraki Y and
Ozono K: Genomic organization of the human chondromodulin-1 gene
containing a promoter region that confers the expression of
reporter gene in chondrogenic ATDC5 cells. J Bone Miner Res.
15:421–429. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou H, Kepa JK, Siegel D, Miura S, Hiraki
Y and Ross D: Benzene metabolite hydroquinone up-regulates
chondromodulin-I and inhibits tube formation in human bone marrow
endothelial cells. Mol Pharmacol. 76:579–587. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai A-C, Pan S-L, Sun H-L, Wang CY, Peng
CY, Wang SW, Chang YL, Kuo SC, Lee KH and Teng CM: CHM-1, a new
vascular targeting agent, induces apoptosis of human umbilical vein
endothelial cells via p53-mediated death receptor 5 up-regulation.
J Biol Chem. 285:5497–5506. 2010. View Article : Google Scholar :
|
|
13
|
Wang S-W, Pan S-L, Huang Y-C, Guh JH,
Chiang PC, Huang DY, Kuo SC, Lee KH and Teng CM: CHM-1, a novel
synthetic quinolone with potent and selective antimitotic antitumor
activity against human hepatocellular carcinoma in vitro and in
vivo. Mol Cancer Ther. 7:350–360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu SC, Yang JS, Kuo CL, Lo C, Lin JP,
Hsia TC, Lin JJ, Lai KC, Kuo HM, Huang LJ, et al: Novel quinolone
CHM-1 induces apoptosis and inhibits metastasis in a human
osterogenic sarcoma cell line. J Orthop Res. 27:1637–1644. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Patra D and Sandell LJ: Antiangiogenic and
anticancer molecules in cartilage. Expert Rev Mol Med. 14:e102012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steck E, Bertram H, Abel R, Chen B, Winter
A and Richter W: Induction of intervertebral disc-like cells from
adult mesenchymal stem cells. Stem Cells. 23:403–411. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pirker R, Pereira JR, von Pawel J,
Krzakowski M, Ramlau R, Park K, de Marinis F, Eberhardt WE,
Paz-Ares L, Störkel S, et al: EGFR expression as a predictor of
survival for first-line chemotherapy plus cetuximab in patients
with advanced non-small-cell lung cancer: Analysis of data from the
phase 3 FLEX study. Lancet Oncol. 13:33–42. 2012. View Article : Google Scholar
|
|
18
|
Dalby B, Cates S, Harris A, Ohki EC,
Tilkins ML, Price PJ and Ciccarone VC: Advanced transfection with
Lipofectamine 2000 reagent: Primary neurons, siRNA, and
high-throughput applications. Methods. 33:95–103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu C, Jung S, Luo S, Meng F, Zhu X, Park
TG and Zhong Z: Co-delivery of siRNA and paclitaxel into cancer
cells by biodegradable cationic micelles based on
PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials.
31:2408–2416. 2010. View Article : Google Scholar
|
|
20
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar
|
|
21
|
Mera H, Kawashima H, Yoshizawa T,
Ishibashi O, Ali MM, Hayami T, Kitahara H, Yamagiwa H, Kondo N,
Ogose A, et al: Chondromodulin-1 directly suppresses growth of
human cancer cells. BMC Cancer. 9:1662009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Callow MG, Clairvoyant F, Zhu S, Schryver
B, Whyte DB, Bischoff JR, Jallal B and Smeal T: Requirement for
PAK4 in the anchorage-independent growth of human cancer cell
lines. J Biol Chem. 277:550–558. 2002. View Article : Google Scholar
|
|
23
|
Schwartz MA and Assoian RK: Integrins and
cell proliferation: Regulation of cyclin-dependent kinases via
cytoplasmic signaling pathways. J Cell Sci. 114:2553–2560.
2001.PubMed/NCBI
|
|
24
|
Schwartz MA and Ginsberg MH: Networks and
crosstalk: Integrin signalling spreads. Nat Cell Biol. 4:E65–E68.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayami T, Shukunami C, Mitsui K, Endo N,
Tokunaga K, Kondo J, Takahashi HE and Hiraki Y: Specific loss of
chondromodulin-I gene expression in chondrosarcoma and the
suppression of tumor angiogenesis and growth by its recombinant
protein in vivo. FEBS Lett. 458:436–440. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sachdev SW, Dietz UH, Oshima Y, Lang MR,
Knapik EW, Hiraki Y and Shukunami C: Sequence analysis of zebrafish
chondromodulin-1 and expression profile in the notochord and
chondrogenic regions during cartilage morphogenesis. Mech Dev.
105:157–162. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klinger P, Surmann-Schmitt C, Brem M,
Swoboda B, Distler JH, Carl HD, von der Mark K, Hennig FF and Gelse
K: Chondromodulin 1 stabilizes the chondrocyte phenotype and
inhibits endochondral ossification of porcine cartilage repair
tissue. Arthritis Rheum. 63:2721–2731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen K-F, Tai W-T, Chu P-Y, et al: STAT3
mediates regorafenib-induced apoptosis in hepatocellular carcinoma.
Clin Cancer Res. 20:5768–5776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fujii M, Furumatsu T, Yokoyama Y, Kanazawa
T, Kajiki Y, Abe N and Ozaki T: Chondromodulin-I derived from the
inner meniscus prevents endothelial cell proliferation. J Orthop
Res. 31:538–543. 2013. View Article : Google Scholar
|
|
30
|
Shukunami C and Hiraki Y: Role of
cartilage-derived anti-angiogenic factor, chondromodulin-I, during
endochondral bone formation. Osteoarthritis Cartilage. 9(Suppl A):
S91–S101. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fang W, Friis TE, Long X and Xiao Y:
Expression of chondromodulin-1 in the temporomandibular joint
condylar cartilage and disc. J Oral Pathol Med. 39:356–360.
2010.
|
|
32
|
Takeda K, Clausen BE, Kaisho T, Tsujimura
T, Terada N, Förster I and Akira S: Enhanced Th1 activity and
development of chronic enterocolitis in mice devoid of Stat3 in
macrophages and neutrophils. Immunity. 10:39–49. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grivennikov S, Karin E, Terzic J, Mucida
D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H,
Eckmann L, et al: IL-6 and Stat3 are required for survival of
intestinal epithelial cells and development of colitis-associated
cancer. Cancer Cell. 15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Corvinus FM, Orth C, Moriggl R, Tsareva
SA, Wagner S, Pfitzner EB, Baus D, Kaufmann R, Huber LA, Zatloukal
K, et al: Persistent STAT3 activation in colon cancer is associated
with enhanced cell proliferation and tumor growth. Neoplasia.
7:545–555. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sherry MM, Reeves A, Wu JK and Cochran BH:
STAT3 is required for proliferation and maintenance of multipotency
in glioblastoma stem cells. Stem Cells. 27:2383–2392. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao Q, Wolfgang MJ, Neschen S, Morino K,
Horvath TL, Shulman GI and Fu XY: Disruption of neural signal
transducer and activator of transcription 3 causes obesity,
diabetes, infertility, and thermal dysregulation. Proc Natl Acad
Sci USA. 101:4661–4666. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aggarwal BB, Sethi G, Ahn KS, Sandur SK,
Pandey MK, Kunnumakkara AB, Sung B and Ichikawa H: Targeting
signal-transducer-and-activator-of-transcription-3 for prevention
and therapy of cancer: Modern target but ancient solution. Ann NY
Acad Sci. 1091:151–169. 2006. View Article : Google Scholar
|
|
38
|
Blaskovich MA, Sun J, Cantor A, Turkson J,
Jove R and Sebti SM: Discovery of JSI-124 (cucurbitacin I), a
selective Janus kinase/signal transducer and activator of
transcription 3 signaling pathway inhibitor with potent antitumor
activity against human and murine cancer cells in mice. Cancer Res.
63:1270–1279. 2003.PubMed/NCBI
|
|
39
|
Chen T, Wang LH and Farrar WL: Interleukin
6 activates androgen receptor-mediated gene expression through a
signal transducer and activator of transcription 3-dependent
pathway in LNCaP prostate cancer cells. Cancer Res. 60:2132–2135.
2000.PubMed/NCBI
|
|
40
|
Aggarwal BB, Kunnumakkara AB, Harikumar
KB, Gupta SR, Tharakan ST, Koca C, Dey S and Sung B: Signal
transducer and activator of transcription-3, inflammation, and
cancer: How intimate is the relationship? Ann NY Acad Sci.
1171:59–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
De Simone V, Franzè E, Ronchetti G,
Colantoni A, Fantini MC, Di Fusco D, Sica GS, Sileri P, MacDonald
TT, Pallone F, et al: Th17-type cytokines, IL-6 and TNF-α
synergistically activate STAT3 and NF-κB to promote colorectal
cancer cell growth. Oncogene 2014. Sep 1–2014.(Epub ahead of
print). View Article : Google Scholar
|
